Clinical Trials Logo

Filter by:
NCT ID: NCT00946205 Completed - Rectal Prolapse Clinical Trials

Laparoscopic Rectopexy for Rectal Prolapse

Start date: September 2006
Phase: N/A
Study type: Interventional

The aim of the present prospective, double-blind, randomized study is to study whether laparoscopic anterior mesh rectopexy is as good as laparoscopic posterior rectopexy with respect to obstructive defecation afterwards.

NCT ID: NCT00943826 Completed - Glioblastoma Clinical Trials

A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Start date: June 29, 2009
Phase: Phase 3
Study type: Interventional

This 2 arm study investigated the efficacy and safety of the addition of bevacizumab to the current standard of care (multimodality therapy of concurrent radiotherapy plus temozolomide followed by adjuvant temozolomide) as compared to the current standard of care alone. Participants were randomly assigned to either the bevacizumab (10 milligrams per kilogram (mg/kg) intravenously [IV] once every 2 week [q2w]) or the placebo arm, in combination with radiation therapy (total dose 60 Gray [Gy], administered as 2 Gy fractions, 5 days/week) plus temozolomide (75 milligrams per meter squared [mg/m^2] oral administration [po] daily) for 6 weeks. After a 4 week treatment break, participants continued to receive bevacizumab (10 mg/kg IV q2w) or placebo, plus temozolomide (150-200 mg/m^2 po daily on days 1-5 of each 4 week cycle) for 6 cycles of maintenance treatment or until disease progression or unacceptable toxicity, whichever occured first. Following the maintenance phase, bevacizumab (15 mg/kg iv every 3 weeks [q3w]) or placebo monotherapy continued. The time on study treatment was until disease progression.

NCT ID: NCT00940602 Completed - Clinical trials for Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

TELESTO
Start date: March 22, 2010
Phase: Phase 2
Study type: Interventional

This was a randomized, double-blind trial to evaluate deferasirox vs placebo in patients with myelodysplastic syndromes (low/int-1 risk) and transfusional iron overload .The trial was conducted in 17 countries, started in 2010 and ended in 2018.

NCT ID: NCT00940134 Completed - Obesity Clinical Trials

Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.

INGEAR-1
Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of intravenous infusion of two gastrointestinal hormones, PYY3-36 and GLP-1, alone and in combination, on appetite in healthy obese men. The investigators hypothesize that an intravenous infusion of each hormone alone will decrease food intake at a buffet meal and decrease appetite, and that in combination, there will be a greater decrease in food intake and appetite compared to each hormone alone.

NCT ID: NCT00939679 Completed - Obesity Clinical Trials

Effect of Gastric Bypass Surgery on Energy Metabolism

ERGEM
Start date: September 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the short term and long term effects of Roux-en-Y gastric bypass (RYGB) surgery on energy expenditure, gastrointestinal and appetite regulating hormone levels, and appetite sensation. We hypothesize that following RYGB surgery, metabolism will be elevated in comparison to patients who have not yet had RYGB but who are losing weight simultaneously using a low calorie diet. We further hypothesize that this higher metabolism will be associated with alterations in fasting and postmeal levels of gastrointestinal and appetite regulating hormones. Long term (1.5 years after RYGB), we hypothesize that differences in metabolism, body composition, and hormone levels will distinguish between patients who have maintained their weight loss after RYGB vs those who have regained weight.

NCT ID: NCT00939107 Completed - Low Back Pain Clinical Trials

The McKenzie Method Versus Manipulation for Patients With Chronic Low Back Pain

Start date: September 2003
Phase: N/A
Study type: Interventional

Introduction: The McKenzie method as well as spinal manipulation is commonly used for the treatment of low back pain throughout the western world. Recently, the need for studies testing the effect of treatment strategies to specific diagnostic subgroups of patients has been emphasized. The present study aims to compare the effectiveness of the McKenzie method and chiropractic manipulation, information, and advice for patients with clinical signs of persistent symptoms originating from a diskus in the low back. Methods: After clinical screening 350 patients with or without leg pain who presented with centralization of symptoms or signs of disc herniation were randomized to the McKenzie group or the manipulation group. The outcome measures, Roland Morris Disability Questionnaire, 11 point numerical pain scale, 6 point global perceived change scale, and quality of life (Short Form-36) were assessed at baseline, at end of treatment, and at 2 and 12 months follow-up.

NCT ID: NCT00938808 Completed - Obesity Clinical Trials

Long-term Intervention With Weight Loss in Patients With Concomitant Obesity and Knee Osteoarthritis. The LIGHT Study

LIGH T
Start date: June 2009
Phase: N/A
Study type: Interventional

Obesity and osteoarthritis (OA) co-exist in an increasing part of the population. The two diseases intertwine in several ways. The evolution in the population shows a tendency towards deterioration of both by increasing general age and weight. The two diseases share pathogenetic features and the development of one disease increases the risk of the other and may be the onset of a vicious circle. There is a link between treatments of these two diseases as well. There is now solid (gold) evidence that by treating effectively the obesity of patients with co-occurring OA, the functional status is dramatically ameliorated; the short-term results are equal to that of a joint replacement. The long-term efficacy of a weight loss remains to be shown. OA is definitely one of many diseases in which obesity must be taken seriously into account when planning a correct treatment of patients. This trial is an extension of the former CAROT trial NCT00655941. The participants of this trial are recruited for a prolongation of the dietary intervention consisting of a group therapy with low-energy diet in a randomized, two group (each n = 75 patients) study of maintenance of weight loss by continuing with supplementary either 3 x 5 weeks dietary supplements only or once-daily supplement. The hypothesis is that maintenance of the already induced weight loss is most efficiently ensured by the once-daily program.

NCT ID: NCT00938210 Completed - Fatigue Clinical Trials

Rehabilitation Following Laparoscopic Colonic Surgery

Start date: May 2009
Phase: N/A
Study type: Interventional

The standard procedure for treating colonic cancer is changing from open surgery to laparoscopic surgery. Following open colonic surgery patients are fatigued and loss body mass and have a reduction in physical function, but the investigators do not know if this is also the case following laparoscopic surgery. This study examines how fatigue, quality of life, physical function, and body composition changes following laparoscopic colonic surgery. Patients are examined preoperatively and postoperative day 10 and 30.

NCT ID: NCT00937885 Completed - Clinical trials for Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.

Consequences From Use of Reminiscence: a Randomised Intervention Study in Ten Danish Nursing Homes

Start date: August 2005
Phase: N/A
Study type: Interventional

Reminiscence is the systematic use of memories and recollections to strengthen self-identity and self-worth. The study aim was to investigate the consequences for nursing home residents and staff of integrating reminiscence into daily nursing care. Ten nursing homes were randomised into either an Intervention Group, who implemented reminiscence, or a Control Group, who continued with usual care. Data were collected at baseline and again 6 and 12 months after the intervention start. Results suggested that use of reminiscence can improve residents' quality of life and possibly delay progression in dementia symptoms. Nursing staff can experience greater satisfaction with personal and professional roles and develop a more positive view of the residents.

NCT ID: NCT00937625 Completed - Melanoma Clinical Trials

T-cell Based Immunotherapy for of Melanoma

Start date: June 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to investigate the toxicity and clinical response of therapy with tumor infiltrating lymphocytes as treatment for advanced melanoma. Patient will receive a single treatment consisting of conditioning chemotherapy for seven days (cyclophosphamide for two days and fludarabine for five days), intravenous infusion of high number of in vitro expanded tumor infiltrating lymphocytes followed by two weeks with daily low-dose interleukine-2. Patients will be evaluated for toxicity, tumor response, and immune response. After the first 6 patients the treatment with IL-2 has been changed to include higher doses of IL-2 (see intervention)